Search results for " Cardiology"

showing 10 items of 242 documents

Less invasive (common) femoral artery aneurysm repair using endografts and limited dissection

2013

Objective We report our experience with the treatment of femoral artery aneurysms (FAAs) under local anaesthesia with limited dissection, using endografts to facilitate the proximal anastomosis and some distal anastomoses. Method Between January 2006 and December 2010, six males, mean age 72 years (range, 65–80 years) with FAAs were treated at the University Hospital of Zurich. All operations were performed under local anaesthesia with analgosedation, except for one performed under spinal anaesthesia. After limited dissection and puncture of the anterior wall of the FAA, a sheath and a self-expanding endograft were introduced over a guide wire and with fluoroscopy they were guided intralumi…

Malemedicine.medical_specialtyAnastomosismedicine.medical_treatmentEndograft610 Medicine & healthFemoral arteryDissection (medical)AnastomosisSettore MED/22 - Chirurgia Vascolare2705 Cardiology and Cardiovascular MedicineAneurysmmedicine.arteryDeep Femoral ArteryHumansMedicineAgedMedicine(all)Aged 80 and over10042 Clinic for Diagnostic and Interventional Radiologybusiness.industryEndovascular ProceduresBalloon catheterExternal iliac arteryStentmedicine.diseaseAneurysmBlood Vessel Prosthesis10020 Clinic for Cardiac Surgery2746 SurgerySurgeryFemoral ArteryCommon femoral arteryFemaleSurgeryRadiologyCardiology and Cardiovascular MedicinebusinessCommon femoral artery Aneurysm Endograft Anastomosis
researchProduct

Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic t…

2015

Aims The impact of exercise training on the right heart and pulmonary circulation has not yet been invasively assessed in patients with pulmonary hypertension (PH) and right heart failure. This prospective randomized controlled study investigates the effects of exercise training on peak VO2/kg, haemodynamics, and further clinically relevant parameters in PH patients. Methods and results Eighty-seven patients with pulmonary arterial hypertension and inoperable chronic thrombo-embolic PH (54% female, 56 ± 15 years, 84% World Health Organization functional class III/IV, 53% combination therapy) on stable disease-targeted medication were randomly assigned to a control and training group. Medica…

Malemedicine.medical_specialtyCardiac outputHypertension PulmonaryVentricular Dysfunction RightCardiac indexHemodynamics610 Medicine & health030204 cardiovascular system & hematology2705 Cardiology and Cardiovascular Medicine03 medical and health sciences0302 clinical medicineOxygen ConsumptionHeart RateInternal medicineThromboembolismHeart rateNatriuretic Peptide BrainmedicineHumansProspective StudiesPulmonary Wedge PressureCardiac OutputPulmonary wedge pressureProspective cohort studyAnalysis of VarianceExercise Tolerancebusiness.industryMiddle Agedmedicine.diseasePulmonary hypertensionPeptide FragmentsSurgeryExercise Therapymedicine.anatomical_structureTreatment Outcome030228 respiratory systemChronic DiseaseVascular resistanceCardiologyExercise TestFemaleVascular Resistance10178 Clinic for PneumologyCardiology and Cardiovascular MedicinebusinessBiomarkersEuropean heart journal
researchProduct

Cardiac troponin I and T: Exploring popularity with Google Trends

2020

The implementation of high-sensitivity cardiac troponin T (hs-cTnT) assays and a cutoff based on the 99th cTnT percentile in the evaluation of patients with suspected acute coronary syndrome has not been uniform due to uncertain effects on health benefits and utilization of limited resources.Clinical and laboratory data from patients with chest pain or dyspnea at the emergency de¬partment (ED) were evaluated before (n = 20516) and after (n = 18485) the lowering of the hs-cTnT cutoff point from 40 ng/L to the 99th hs-cTnT percentile of 14 ng/L in February 2012. Myocardial infarction (MI) was diagnosed at the discretion of the attending clinicians responsible for the patient.Following lowerin…

Malemedicine.medical_specialtyCardiac troponinMEDLINEGoogle TrendsClinical CardiologyElectrocardiographyPatient AdmissionTroponin TPredictive Value of TestsInternal medicinemedicineHumansHospital MortalityAcute Coronary SyndromeHospital CostsIntensive care medicineAgedRetrospective StudiesAged 80 and overCardiac troponins popularity Google Trendspopularitybusiness.industryTroponin IGeneral MedicineMiddle AgedPopularityHospitalsHospitalizationSurvival RateCardiologyFemaleCardiac troponinsCardiology and Cardiovascular MedicinebusinessEmergency Service HospitalBiomarkersFollow-Up Studies
researchProduct

Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.

2021

Over the past 2 decades, chronic total occlusion (CTO) percutaneous coronary intervention has developed into its own subspecialty of interventional cardiology. Dedicated terminology, techniques, devices, courses, and training programs have enabled progressive advancements. However, only a few randomized trials have been performed to evaluate the safety and efficacy of CTO percutaneous coronary intervention. Moreover, several published observational studies have shown conflicting data. Part of the paucity of clinical data stems from the fact that prior studies have been suboptimally designed and performed. The absence of standardized end points and the discrepancy in definitions also prevent…

Malemedicine.medical_specialtyClinical trial protocols as topicmedicine.medical_treatmentPsychological intervention030204 cardiovascular system & hematologySubspecialtylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawPhysiology (medical)MedicineHumansMedical physics030212 general & internal medicineCoronary VesselClinical Trials as TopicInterventional cardiologybusiness.industryClinical study designPercutaneous coronary interventionCoronary VesselsCoronary OcclusionCoronary occlusionEndpoint determination:Myocardial revascularizationObservational studyFemaleCardiology and Cardiovascular MedicinebusinessCirculation
researchProduct

Independent Impact of RV Involvement on In-Hospital Outcome of Patients With Takotsubo Syndrome

2016

Takotsubo syndrome (TTS) is an acute clinical condition characterized by transient left ventricular dysfunction and reversible heart failure, the pathogenetic mechanism of which remains unclear. Although left ventricular apical ballooning is the most frequent morphological pattern, other variant forms have been described (1). In addition, right ventricular involvement (RVi), characterized by the presence of right ventricular (RV) apical dysfunction (biventricular ballooning), has been documented using echocardiography or cardiac magnetic resonance imaging. However, the prevalence, clinical profile, and in-hospital course of TTS patients with RVi are still not well defined. To date, although…

Malemedicine.medical_specialtyCoronary Artery SpasmShock Cardiogenic030204 cardiovascular system & hematologyTakotsubo Cardiomyopathy Cardiogenic Shock Coronary Artery SpasmVentricular Function Left03 medical and health sciences0302 clinical medicineText miningPredictive Value of TestsRisk FactorsTakotsubo CardiomyopathyInternal medicineNuclear Medicine and ImagingmedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineHospital MortalityProspective StudiesAgedAged 80 and overCardiogenic ShockTakotsubo syndromeApical ballooningMechanism (biology)business.industryTakotsubo SyndromeRadiology Nuclear Medicine and Imaging; Cardiology and Cardiovascular MedicineMiddle Agedmedicine.diseasePrognosisHospitalizationHospital outcomesEchocardiographyHeart failureCardiologyVentricular Function RightFemalebusinessRadiologyCardiology and Cardiovascular Medicine
researchProduct

Cinical outcomes of Endurant II stent-graft for infrarenal aortic aneurysm repair: comparison of on-label versus off-label use.

2016

Purpose We aimed to compare the outcomes of the Endurant II (Medtronic) stent-graft used under instructions for use versus off-label in high-risk patients considered unfit for conventional surgery. Methods Data from patients treated with the Endurant II stent-graft between December 2012 and March 2015 were retrospectively analyzed. Sixty-four patients were included. Patients were assigned to group A if treated under instructions for use (n=34, 53%) and to group B if treated off-label (n=30, 47%). Outcome measures included perioperative mortality and morbidity, survival, freedom from reintervention, endoleak incidence, in-hospital length of stay, and mean stent-graft component used. Mean fol…

Malemedicine.medical_specialtyEndoleakmedicine.medical_treatment030204 cardiovascular system & hematologyProsthesis DesignSettore MED/22 - Chirurgia VascolareRisk AssessmentGroup B03 medical and health sciencesAortic aneurysm0302 clinical medicinePostoperative ComplicationsOcclusionInterventional RadiologyMedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineSurvival analysisAgedAged 80 and overbusiness.industryRadiology Nuclear Medicine and Imaging; Cardiology and Cardiovascular MedicineEndovascular ProceduresStentPerioperativeOff-Label UseMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryBlood Vessel ProsthesisTreatment OutcomeFemaleStentsCardiology and Cardiovascular MedicinebusinessComplicationAbdominal surgeryAortic Aneurysm AbdominalDiagnostic and interventional radiology (Ankara, Turkey)
researchProduct

Gelatinases and their tissue inhibitors in a group of subjects with obstructive sleep apnea syndrome.

2016

Obstructive sleep apnea syndrome (OSAS) is associated with an elevated risk of cardiovascular events and stroke. Matrix metalloproteinases (MMPs) are endopeptidases involved in extracellular matrix degradation and then in the development and progression of cardiovascular diseases. Our aim was to evaluate plasma levels of gelatinases (MMP-2 and MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in a group of subjects with OSAS. We enrolled 48 subjects (36 men and 12 women; mean age 49.7 ± 14.68 yrs) with OSAS diagnosed with a 1-night cardiorespiratory study and then we subdivided these subjects into two subgroups according to the apnea/hypopnea index (AHI): Low (L = 21 subjects with AHI …

Malemedicine.medical_specialtyGelatinasesSettore MED/09 - Medicina InternaPhysiologyMMP-2; MMP-9; obstructive sleep apnea; TIMP-1; TIMP-2; Disease Progression; Female; Gelatinases; Humans; Male; Middle Aged; Sleep Apnea Obstructive; Tissue Inhibitor of Metalloproteinase-1; Physiology; Hematology; Cardiology and Cardiovascular Medicine; Physiology (medical)030204 cardiovascular system & hematologyMatrix metalloproteinaseGastroenterologyTIMP-203 medical and health sciencesTIMP-10302 clinical medicinePhysiology (medical)Internal medicinemedicineHumansStrokeobstructive sleep apneaOxygen saturation (medicine)Sleep Apnea ObstructiveTissue Inhibitor of Metalloproteinase-1MMP-2business.industryApneaCardiorespiratory fitnessHematologyMiddle Agedmedicine.diseasenervous system diseasesrespiratory tract diseasesObstructive sleep apneaEndocrinology030228 respiratory systemGelatinaseGelatinasesDisease ProgressionFemalemedicine.symptomMMP-9Settore MED/36 - Diagnostica Per Immagini E RadioterapiaCardiology and Cardiovascular MedicinebusinessHypopneaHumanClinical hemorheology and microcirculation
researchProduct

New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-come…

2019

Percutaneous coronary intervention (PCI) has been established as an alternative treatment option to coronary artery by-pass graft (CABG) surgery in patients with left main coronary artery disease (LMCAD). Whether the findings of randomized controlled trials are applicable to a real-world patient population is unclear.We compared the outcomes of PCI with new-generation DES in the all-comer, international, multicenter DELTA-2 registry retrospectively evaluating mid-term clinical outcomes with the historical CABG cohort enrolled in the DELTA-1 registry according to the EXCEL key inclusion or exclusion criteria. The primary endpoint was the composite of death, myocardial infarction, or stroke a…

Malemedicine.medical_specialtyInternationalitymedicine.medical_treatmenteducationPopulation610 Medicine & healthCoronary Artery Disease030204 cardiovascular system & hematology2705 Cardiology and Cardiovascular Medicinelaw.inventionDELTA-2 registry; Drug-eluting stents; EXCEL trial; Left main coronary artery; Cardiology and Cardiovascular Medicine03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionRandomized controlled triallawInternal medicineDELTA-2 registrymedicineClinical endpointHumanscardiovascular diseases030212 general & internal medicineMyocardial infarctionRegistriesMortalityeducationDrug-eluting stentsAgedRetrospective StudiesAged 80 and overeducation.field_of_studyProportional hazards modelbusiness.industryEXCEL trialHazard ratioPercutaneous coronary interventionLeft main coronary arteryMiddle Agedmedicine.diseasehumanitiessurgical procedures operativeConventional PCI10209 Clinic for CardiologyFemalebusinessCardiology and Cardiovascular Medicine
researchProduct

Impact of routine invasive strategy on outcomes in patients with non-ST-segment elevation myocardial infarction during 2005–2014: A report from the P…

2020

Background: Non-ST-segment elevation myocardial infarction (NSTEMI) has become the most frequently encountered type of myocardial infarction. The patient clinical profile and management has evolved over the past decade. As there is still a scarcity of data on the latest trends in NSTEMI, changes herein were observed and assessed in the treatment and outcomes in Poland between 2005 and 2014. Methods: A total of 197,192 patients with NSTEMI who enrolled in the Polish Registry of Acute Coronary Syndromes (PL-ACS) between 2005 and 2014 were analyzed. In-hospital and 12-month mortality were assessed. Results: Coronary angiography use increased from 35.8% in 2005–2007 to 90.7% in 2012–2014 (p < 0…

Malemedicine.medical_specialtyInvasive strategyMultivariate analysismedicine.medical_treatmentnon-ST-elevation myocardial infarctionMyocardial InfarctionClinical CardiologyoutcomesCoronary AngiographyVentricular Function Lefttemporal trendsPercutaneous Coronary InterventionRisk FactorsInternal medicinemedicineST segmentHumansinvasive strategyMyocardial infarctionRegistriesAcute Coronary SyndromeChildNon-ST Elevated Myocardial Infarctionbusiness.industryMortality ratePercutaneous coronary interventionStroke VolumeGeneral MedicineOdds ratioMiddle Agedmedicine.diseaseConfidence intervalTreatment OutcomeCardiologyFemalePolandCardiology and Cardiovascular Medicinebusiness
researchProduct

Simultaneous appearance of leukemoid reaction and phlegmasia cerulea dolens

2012

A leukemoid reaction is an extreme form of reactive leukocytosis defined as granulocytic leukocytosis above 50 × 109/L produced by normal bone marrow, mostly in response to systemic infection or cancer. The mechanism as to how the haematopoetic system is altered to elevate production of myeloid cells is not known. A 69-year-old man presented with phlegmasia cerulea dolens caused by massive iliofemoral thrombosis. His workout at admission revealed absolute white blood cell count of 73.4 × 109/L, with neutrophil granulocyte of 68.5 × 109/L. The new increase in white blood cell count happened at day 5 after admission, when the haematoma of the anteromedial thigh was evacuated in general anaes…

Malemedicine.medical_specialtyNeutrophil granulocyte610 Medicine & healthGastroenterologySettore MED/22 - Chirurgia Vascolare2705 Cardiology and Cardiovascular MedicineLeukocyte CountInternal medicineWhite blood cellmedicineHumansGeneral anaesthesiaLeukocytosisAgedPhlegmasia cerulea dolensphlegmasia cerulea dolenHematomabusiness.industryRemission InductionThrombosisGeneral MedicineThrombophlebitismedicine.diseaseThrombosisSystemic Inflammatory Response Syndromeleukemoid reaction10020 Clinic for Cardiac SurgerySurgerySystemic inflammatory response syndromemedicine.anatomical_structurephlegmasia cerulea dolens; leukemoid reactionmedicine.symptomCardiology and Cardiovascular MedicinebusinessLeukemoid reaction
researchProduct